Điều trị bệnh tim mạch ở bệnh nhân ung thư

Heron M, Hoyert DL, Murphy SL et al (2009) Deaths: final data for 2006. Natl Vital Stat Rep 57(14):1–134 Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67(1):10–18 Yeh ET (2006) Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med 57:485–498 Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32(2):302–314 Steinherz LJ, Steinherz PG, Tan CT et al (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266(12):1672–1677 Gottdiener JS, Appelbaum FR, Ferrans VJ et al (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141(6):758–763 Quezado ZM, Wilson WH, Cunnion RE et al (1993) High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. Ann Intern Med 118(1):31–36 Guarneri V, Lenihan DJ, Valero V et al (2006) Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience. J Clin Oncol 24(25):4107–4115 Tan-Chiu E, Yothers G, Romond E et al (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23(31):7811–7819 Gonzalez-Angulo AM, Hortobagyi GN, Esteva FJ (2006) Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer. Oncologist 11(8):857–867 Rock EP, Goodman V, Jiang JX et al (2007) Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist 12(1):107–113 Force T, Krause DS, Van Etten RA (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 7(5):332–344 Forni M de, Malet-Martino MC, Jaillais P et al (1992) Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 10(11):1795–1801 Tsavaris N, Kosmas C, Vadiaka M et al (2002) Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy – a survey of 427 patients. Med Sci Monit 8(6):PI51–PI57 Kosmas C, Kallistratos MS, Kopterides P et al (2008) Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 134(1):75–82 Lejonc JL, Vernant JP, Macquin J, Castaigne A (1980) Myocardial infarction following vinblastine treatment. Lancet 2(8196):692 Mandel EM, Lewinski U, Djaldetti M (1975) Vincristine-induced myocardial infarction. Cancer 36(6):1979–1982 Fajardo LF, Stewart JR (1972) Coronary artery disease after radiation. N Engl J Med 286(23):1265–1266 Orzan F, Brusca A, Conte MR et al (1993) Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J 69(6):496–500 Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290(21):2831–2837 Adabag AS, Dykoski R, Ward H, Anand IS (2004) Critical stenosis of aortic and mitral valves after mediastinal irradiation. Catheter Cardiovasc Interv 63(2):247–250 Maisch B, Seferovic PM, Ristic AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25(7):587–610 Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6(8):557–565 Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 270(16):1949–1955 Hidalgo JD, Krone R, Rich MW et al (2004) Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant 34(7):615–619 Poldermans D, Schouten O, Vidakovic R et al (2007) A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 49(17):1763–1769 Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116(17):1971–1996 Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118(10):1134–1141 Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation Hunt SA, Abraham WT, Chin MH et al (2009) 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation Labianca R, Beretta G, Clerici M et al (1982) Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 68(6):505–510 Gridelli C, Aapro M, Ardizzoni A et al (2005) Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol 23(13):3125–3137 Cannon CP, Braunwald E, McCabe CH et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350(15):1495–1504 Sarkiss MG, Yusuf SW, Warneke CL et al (2007) Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 109(3):621–627 Heidenreich PA, Schnittger I, Strauss HW et al (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol 25(1):43–49 Chandra S, Lenihan DJ, Wei W et al (2009) Myocardial perfusion imaging and cardiovascular outcomes in a cancer population. Tex Heart Inst J 36(3):205–213 Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15):1503–1516 Frye RL, August P, Brooks MM et al (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360(24):2503–2515 Fraker TD Jr, Fihn SD, Gibbons RJ et al (2007) 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 50(23):2264–2274 Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116(7):e148–e304 Helft G, Dambrin G, Zaman A et al (2009) Percutaneous coronary intervention in anticoagulated patients via radial artery access. Catheter Cardiovasc Interv 73(1):44–47 Brilakis ES, Orford JL, Fasseas P et al (2005) Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96(4):512–514 Cardiac Society of Australia and New Zealand (2010) Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery. Heart Lung Circ 19(1):2–10 Broad L, Lee T, Conroy M et al (2007) Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 98(1):19–22 Gross CM, Posch MG, Geier C et al (2008) Subacute coronary stent thrombosis in cancer patients. J Am Coll Cardiol 51(12):1232–1233 Heir JS, Gottumukkala V, Singh M et al (2010) Coronary stents and noncardiac surgery: current clinical challenges and conundrums. Prev Cardiol 13(1):8–13 Gansera B, Schmidtler F, Angelis I et al (2007) Quality of internal thoracic artery grafts after mediastinal irradiation. Ann Thorac Surg 84(5):1479–1484 Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429 Tornio A, Pasanen MK, Laitila J et al (2005) Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8. Basic Clin Pharmacol Toxicol 97(2):104–108 Gonyeau MJ, Yuen DW (2010) A clinical review of statins and cancer: helpful or harmful? Pharmacotherapy 30(2):177–194 Khemasuwan D, Divietro ML, Tangdhanakanond K et al (2010) Statins decrease the occurrence of venous thromboembolism in patients with cancer. Am J Med 123(1):60–65 Serebruany VL (2009) Platelet inhibition with prasugrel and increased cancer risks: potential causes and implications. Am J Med 122(5):407–408 Maisch B et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25(7):587–610 Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53(2):157–163 Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23(19):1503–1508 Maisch B et al (2002) Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23(20):1625–1631 Maisch B, Ristic AD, Seferovic P, Tsang TSM (2011) Interventional pericardiology,-Pericardiocentesis, pericardioscopy, balloon pericardiotomy, and intrapericardial therapy (with contributions from S. Pankuweit, R. Maksimovic, H. Rupp, JK Oh, JB Seward, and AJ Tajik). Springer, Berlin Heidelberg Maisch B, Hufnagel G, Kölsch S et al (2004) Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29:624–636